-
421
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
Published 2020-10-01Get full text
Article -
422
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
Published 2021-07-01Get full text
Article -
423
miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles
Published 2012-01-01Get full text
Article -
424
-
425
-
426
Synchronous surgical treatment for brain and heart in the era of pan ⁃ vascular medicine
Published 2024-01-01Get full text
Article -
427
-
428
Endothelial Dysfunction in Childhood Cancer Survivors: A Narrative Review
Published 2021-12-01Get full text
Article -
429
-
430
Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up
Published 2023-06-01Get full text
Article -
431
-
432
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
Published 2022-04-01Get full text
Article -
433
Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma
Published 2023-01-01Get full text
Article -
434
Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
Published 2023-04-01Get full text
Article -
435
The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach
Published 2023-03-01“…Results Over a period of 35 months, 700 patients with glioma followed by our neuro-oncology unit were screened, and 99 were enrolled in the study; most of the patients were excluded for inadequate non-morphological MRI or lack/inadequacy of the tissue samples. …”
Get full text
Article -
436
-
437
The Clinical Significance of Ependymal Enhancement at Presentation in Patients with Malignant Glioma
Published 2015-10-01Get full text
Article -
438
Antimicrobial drug use and the risk of glioma: A case–control study
Published 2023-02-01Get full text
Article -
439
-
440